BioLight Announces Closing of Joint Investment in IOPtima Subsidiary

BioLight announced today that following its announcement on November 25, 2015 of BioLight’s IOPtima Ltd. subsidiary regarding entering into a joint financing agreement with two Asia-based venture capital firms, according to which the New Investors will invest an aggregate amount of US$6.0 million in consideration for the issuance of approximately 29% of IOPtima’s issued and outstanding shares (post investment), on December 28, 2015, all closing terms were completed and IOPtima received the Investment Amount against said share issuance.

Link to complete article

Link to Newsroom

Comments are closed.